BNO 27.1% 6.1¢ bionomics limited

Footmax the long and short of it is that they dont have enough...

  1. 709 Posts.
    lightbulb Created with Sketch. 10
    Footmax the long and short of it is that they dont have enough money for a human trial. they have announced it. Its why fasttrack hasn't been initiated. Its why the share price is so low.

    From memory for the next 210 human trial they need $200 million.

    Deborah Rathjen while CEO burnt through company dollars. Every other week she flew somewhere to a conference and all shareholders got were posters she maybe presented.

    Im not sure why Europe has never been a focus for them. Europe is cheaper to get approvals and it has huge numbers of immigrants suffering ptsd. Obviously FDA is big money but they need to get money badly.

    Its an absolute disaster best possible result is a full buyout next quarter.
watchlist Created with Sketch. Add BNO (ASX) to my watchlist
(20min delay)
Mkt cap ! $33.22M
Open High Low Value Volume
5.3¢ 6.1¢ 5.2¢ $268.0K 4.791M

Buyers (Bids)

No. Vol. Price($)
1 110291 6.0¢

Sellers (Offers)

Price($) Vol. No.
6.1¢ 237381 4
View Market Depth
Last trade - 16.10pm 02/06/2020 (20 minute delay) ?
0.013 ( 14.0 %)
Open High Low Volume
5.3¢ 5.7¢ 5.2¢ 180300
Last updated 11.03am 02/06/2020 (live) ?
BNO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.